A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
Akeso
Shanghai Henlius Biotech
Exelixis
Wuhan Ammunition Life-tech Co., Ltd
HistoSonics, Inc.
Genentech, Inc.
Zymeworks BC Inc.
Akeso
ViroMissile, Inc.
Hoffmann-La Roche
Seagen Inc.
Boston Scientific Corporation
AstraZeneca
SEED Therapeutics, Inc.
Alnylam Pharmaceuticals
DualityBio Inc.
MacroGenics
Coherus Oncology, Inc.
SAPU NANO (US) LLC
Jiangsu Simcere Pharmaceutical Co., Ltd.
Guerbet
Wondercel Biotech (ShenZhen)
inTumo Therapeutics, Inc.
AstraZeneca
Abbisko Therapeutics Co, Ltd
Dysplasia Diagnostics Limited
AstraZeneca
Zhejiang Hisun Pharmaceutical Co. Ltd.
Elephas
Polaris Group
Myeloid Therapeutics
Pfizer
Shanghai JMT-Bio Inc.
TaiRx, Inc.
Replimune Inc.
Eureka Therapeutics Inc.
GV20 Therapeutics
Shanghai Ruiliyuan Biotechnology Co., Ltd.
DualityBio Inc.
AstraZeneca
Tyra Biosciences, Inc
Bayer
7 Hills Pharma, LLC
Travera Inc
Epiliquid Holding, Inc
AbbVie
HC Biopharma Inc.
Lion TCR Pte. Ltd.
iOMEDICO AG